Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis

Atherosclerosis, a leading contributor to cardiovascular diseases (CVDs), is characterized by foam cell formation driven by excessive lipid accumulation in macrophages and vascular smooth muscle cells. This study elucidates the anti-atherosclerotic potential of AWLNH (P3) and PHDL (P4) peptides by a...

Full description

Saved in:
Bibliographic Details
Main Authors: Chathuri Kaushalya Marasinghe, Jae-Young Je
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/23/3/111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850205031979024384
author Chathuri Kaushalya Marasinghe
Jae-Young Je
author_facet Chathuri Kaushalya Marasinghe
Jae-Young Je
author_sort Chathuri Kaushalya Marasinghe
collection DOAJ
description Atherosclerosis, a leading contributor to cardiovascular diseases (CVDs), is characterized by foam cell formation driven by excessive lipid accumulation in macrophages and vascular smooth muscle cells. This study elucidates the anti-atherosclerotic potential of AWLNH (P3) and PHDL (P4) peptides by assessing their effects on foam cell formation, lipid metabolism, and oxidative stress regulation. P3 and P4 effectively suppressed intracellular lipid accumulation in RAW264.7 macrophages and human aortic smooth muscle cells (hASMCs), thereby mitigating foam cell formation. Mechanistically, both peptides modulated cholesterol homeostasis by downregulating cholesterol influx mediators, cluster of differentiation 36 (CD36), and class A1 scavenger receptor (SR-A1), while upregulating cholesterol efflux transporters ATP-binding cassette subfamily A member 1 (ABCA1) and ATP-binding cassette subfamily G member 1 (ABCG1). The activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ) and liver X receptor-alpha (LXR-α) further substantiated their role in promoting cholesterol efflux and restoring lipid homeostasis. Additionally, P3 and P4 peptides exhibited potent antioxidative properties by attenuating reactive oxygen species (ROS) generation through activation of the HO-1/Nrf2 signaling axis. HO-1 silencing via siRNA transfection abolished these effects, confirming HO-1-dependent regulation of oxidative stress and lipid metabolism. Collectively, these findings highlight P3 and P4 peptides as promising therapeutic agents for atherosclerosis by concurrently targeting foam cell formation, cholesterol dysregulation, and oxidative stress, warranting further exploration for potential clinical applications.
format Article
id doaj-art-45a1c790e4304e43aefda5b63e4a6aab
institution OA Journals
issn 1660-3397
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj-art-45a1c790e4304e43aefda5b63e4a6aab2025-08-20T02:11:11ZengMDPI AGMarine Drugs1660-33972025-03-0123311110.3390/md23030111Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in AtherosclerosisChathuri Kaushalya Marasinghe0Jae-Young Je1Department of Food and Life Sciences, Pukyong National University, Busan 48513, Republic of KoreaMajor of Human Bioconvergence, Division of Smart Healthcare, Pukyong National University, Busan 48513, Republic of KoreaAtherosclerosis, a leading contributor to cardiovascular diseases (CVDs), is characterized by foam cell formation driven by excessive lipid accumulation in macrophages and vascular smooth muscle cells. This study elucidates the anti-atherosclerotic potential of AWLNH (P3) and PHDL (P4) peptides by assessing their effects on foam cell formation, lipid metabolism, and oxidative stress regulation. P3 and P4 effectively suppressed intracellular lipid accumulation in RAW264.7 macrophages and human aortic smooth muscle cells (hASMCs), thereby mitigating foam cell formation. Mechanistically, both peptides modulated cholesterol homeostasis by downregulating cholesterol influx mediators, cluster of differentiation 36 (CD36), and class A1 scavenger receptor (SR-A1), while upregulating cholesterol efflux transporters ATP-binding cassette subfamily A member 1 (ABCA1) and ATP-binding cassette subfamily G member 1 (ABCG1). The activation of peroxisome proliferator-activated receptor-gamma (PPAR-γ) and liver X receptor-alpha (LXR-α) further substantiated their role in promoting cholesterol efflux and restoring lipid homeostasis. Additionally, P3 and P4 peptides exhibited potent antioxidative properties by attenuating reactive oxygen species (ROS) generation through activation of the HO-1/Nrf2 signaling axis. HO-1 silencing via siRNA transfection abolished these effects, confirming HO-1-dependent regulation of oxidative stress and lipid metabolism. Collectively, these findings highlight P3 and P4 peptides as promising therapeutic agents for atherosclerosis by concurrently targeting foam cell formation, cholesterol dysregulation, and oxidative stress, warranting further exploration for potential clinical applications.https://www.mdpi.com/1660-3397/23/3/111blue musselbioactive peptidesRAW264.7 macrophagesatherosclerosisinflammationcholesterol flux
spellingShingle Chathuri Kaushalya Marasinghe
Jae-Young Je
Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
Marine Drugs
blue mussel
bioactive peptides
RAW264.7 macrophages
atherosclerosis
inflammation
cholesterol flux
title Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
title_full Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
title_fullStr Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
title_full_unstemmed Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
title_short Ark Shell-Derived Peptides AWLNH (P3) and PHDL (P4) Mitigate Foam Cell Formation by Modulating Cholesterol Metabolism and HO-1/Nrf2-Mediated Oxidative Stress in Atherosclerosis
title_sort ark shell derived peptides awlnh p3 and phdl p4 mitigate foam cell formation by modulating cholesterol metabolism and ho 1 nrf2 mediated oxidative stress in atherosclerosis
topic blue mussel
bioactive peptides
RAW264.7 macrophages
atherosclerosis
inflammation
cholesterol flux
url https://www.mdpi.com/1660-3397/23/3/111
work_keys_str_mv AT chathurikaushalyamarasinghe arkshellderivedpeptidesawlnhp3andphdlp4mitigatefoamcellformationbymodulatingcholesterolmetabolismandho1nrf2mediatedoxidativestressinatherosclerosis
AT jaeyoungje arkshellderivedpeptidesawlnhp3andphdlp4mitigatefoamcellformationbymodulatingcholesterolmetabolismandho1nrf2mediatedoxidativestressinatherosclerosis